Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:24 AM UTC
| NCT Number | NCT05579366 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 884 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT05579366 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 37 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05579366 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05579366 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.